Balyasny Asset Management’s Trueblue TBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-11,666
Closed -$53.1K 3507
2025
Q4
$53.1K Buy
+11,666
New +$59.9K ﹤0.01% 3005
2025
Q3
Sell
-124,626
Closed -$808K 3459
2025
Q2
$808K Buy
+124,626
New +$671K ﹤0.01% 2121
2023
Q3
Sell
-11,744
Closed -$208K 2721
2023
Q2
$208K Buy
+11,744
New +$199K ﹤0.01% 2068
2020
Q4
Sell
-36,063
Closed -$559K 1687
2020
Q3
$559K Buy
36,063
+23,293
+182% +$359K ﹤0.01% 1087
2020
Q2
$195K Buy
+12,770
New +$190K ﹤0.01% 1049
2016
Q2
Sell
-11,689
Closed -$306K 1438
2016
Q1
$306K Buy
+11,689
New +$271K ﹤0.01% 1005

Other funds holding TBI

Balyasny Asset Management's TBI Position: Q1 2026 in Review

Balyasny Asset Management sold out of Trueblue (TBI) in Q1 2026, closing a stake of 11,666 shares — an estimated $53.1K sold.

Balyasny Asset Management first reported a position in TBI in Q1 2016 and held it in 6 quarters. The position peaked at $808K in Q2 2025. 105 funds tracked by Wall St. Rank hold TBI as of Q1 2026.

  • Balyasny Asset Management reported no remaining Trueblue position as of Q1 2026 after selling out during the quarter.
  • Balyasny Asset Management sold 11,666 Trueblue shares in Q1 2026, an estimated $53.1K.
  • Balyasny Asset Management first reported a position in Trueblue in Q1 2016 and held it in 6 quarters.
  • Balyasny Asset Management's Trueblue position peaked at $808K in Q2 2025.
  • 105 funds tracked by Wall St. Rank held Trueblue as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.